Overview
What is Racing Medication And Testing Consortium?
The Racing Medication and Testing Consortium is a nonprofit organization headquartered in Lexington, Kentucky, dedicated to ensuring the integrity of horse racing and the safety of its participants. Through research, education, and advocacy, the Consortium aims to develop and recommend policies and practices regarding the use of medications and methods in training and racing horses. They also foster relationships with regulatory authorities and stakeholder organizations, stimulate research to detect and deter new performance-enhancing substances, and maintain oversight on laboratory capabilities. Additionally, they engage with other organizations to accomplish their mission and disseminate accurate and timely information to stakeholders and the racing press. The Consortium employs a team of approximately three individuals in their mission to promote the health and safety of racehorses and the fairness of competition.
Official website here: www.rmtcnet.com
Is Racing Medication And Testing Consortium legitimate?
Racing Medication And Testing Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. Racing Medication And Testing Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $242,564
Professional Fundraising Fees: $0
Other Salaries and Wages: $69,716
For more financial information, click here
Official website here: www.rmtcnet.com
What is the mission statement of Racing Medication And Testing Consortium?
The Racing Medication and Testing Consortium is dedicated to ensuring the integrity of horse racing and promoting the health and safety of racehorses. Their mission includes engaging in research, education, and advocacy for science-based initiatives that advance these goals. The organization works to develop and recommend policies and prohibited practices regarding the use of medications and methods in horse training and racing. They also strive to become a trusted source of unbiased information on medication, testing, and research. Additionally, the Consortium fosters research to identify and deter the use of substances that enhance or diminish athletic performance. They establish ethical guidelines for the use of therapeutic medications and develop uniform laboratory standards for analyzing controlled medications and banned substances. Oversight of laboratory capabilities is maintained through accreditation programs, audits, and external quality assurance. The Consortium collaborates with regulatory agencies and industry organizations to accomplish their mission. Information is disseminated to stakeholders and the racing press via multiple communication channels.
Official website here: www.rmtcnet.com
Who is the CEO of Racing Medication And Testing Consortium?
Alex Waldrop is the Executive Director of Racing Medication And Testing Consortium.
Official website here: www.rmtcnet.com
What is the revenue of Racing Medication And Testing Consortium?
Racing Medication And Testing Consortium's revenue in 2022 was $718,573.
Official website here: www.rmtcnet.com
Who are the executives of Racing Medication And Testing Consortium and what are their salaries?
The average compensation at Racing Medication And Testing Consortium during 2022 was $104,093. There are 3 employees and 26 volunteers at Racing Medication And Testing Consortium.
Here are 28 key members and their salaries:
- Dr Mary Scollay (Executive Director)
- Michael D Hardy (Executive Director (Partial Year))
- Alex Waldrop (Chair/President) [Trustee/Director]
- Alan Foreman (Vice Chair) [Trustee/Director]
- Hank Zeitlin (Vice Chair) [Trustee/Director]
- Dr Rick Arthur (Secretary) [Trustee/Director]
- Dr Jeff Blea (Director)
- Janet Vanbebber (Treasurer) [Trustee/Director]
- Glenn Blodgett (Director)
- Dr James Meyer (Director)
- Ed Martin (Director)
- Dr Lynn Hovda (Director)
- Dora Delgado (Director)
- Alan Balch (Director)
- Dr William Farmer (Director)
- Tom Robbins (Director)
- John Campbell (Director)
- Terrence Meyocks (Director)
- Dr Stuart Brown Ii (Director)
- Dr Bruce Howard (Director)
- Chauncey Morris (Director)
- Eric Hamelback (Director)
- Keith Chamblin (Director)
- David O'Rourke (Director)
- Matt Iuliano (Director)
- Dr Dionne Benson (Director)
- Andy Schweigardt (Director)
- Rick Gold (Director)
Official website here: www.rmtcnet.com
Where can I find the form 990 for Racing Medication And Testing Consortium?
The Racing Medication And Testing Consortium’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.rmtcnet.com
Learn more at the official website: www.rmtcnet.com
Mission Statement of Racing Medication And Testing Consortium
The Racing Medication and Testing Consortium (RMTC) is a leading organization dedicated to the promotion of horse racing safety and integrity. In pursuit of this mission, the Consortium engages in research, education, and advocacy for science-based initiatives that ensure the health and safety of racehorses and the integrity of competition.
The primary focus of the RMTC is to fund, develop, and promote policy recommendations, as well as enforce strategies regarding the use of medications and methods in connection with training and racing horses. Through its collaborative efforts with state and national racing regulatory authorities and stakeholder organizations, the Consortium strives to become a respected source of unbiased information on medication, testing, and research.
Additionally, the RMTC stimulates, fosters, and solicits research proposals to identify, detect, and deter the use of novel substances and methods that may enhance or diminish athletic performance, and formulate ethical guidelines for the legitimate use of therapeutic medications and methods. The organization also develops and recommends uniform laboratory technical standards, procedures, and performance specifications for analytical methods and instrumentation used in the detection of controlled medications and banned substances.
To maintain oversight on laboratory capabilities and performance, the RMTC accredits laboratories, conducts audits by independent experts, and implements an external quality assurance program sample testing. The organization also identifies and promotes security, surveillance, and intelligence gathering practices and techniques to support enforcement of medication controls and anti-doping regulations. In collaboration with state and federal regulatory agencies, the RMTC works to prevent the synthesis, manufacture, importation, purchase, and sale of illegal or prohibited substances intended for use in horses engaged in racing or training.
The RMTC engages with industry stakeholder organizations responsible for maintaining the integrity of the sport and the health of its participants, and educates them through various programs. The organization also collaborates with other organizations regulating equine sporting disciplines and animal and human sports, both domestic and international, to accomplish its mission. The RMTC disseminates accurate and timely information to stakeholder organizations and the racing press through multiple communication channels.
Impact
This information is meant to be a general summary of Racing Medication And Testing Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Racing Medication And Testing Consortium plays a crucial role in ensuring the integrity of the horse racing sport and the safety of its participants. Through its research, education, and advocacy efforts, the consortium develops and promotes policy recommendations aimed at regulating the use of medications and methods in the training and racing of horses. By collaborating with state and national racing regulatory authorities and stakeholder organizations, the consortium has become a respected source of unbiased information on medication, testing, and research.
Additionally, the consortium works to stimulate and solicit research proposals to detect and deter the use of novel substances that could potentially enhance or diminish athletic performance, ultimately safeguarding the fairness of competition. By defining the ethical and legitimate use of therapeutic medications and formulating guidelines consistent with their use, the consortium seeks to establish best practices for the industry.
Moreover, the consortium is dedicated to maintaining oversight on laboratory capabilities and performance to ensure the accuracy and reliability of testing procedures. By engaging with regulatory agencies and implementing educational programs for industry stakeholders, the consortium plays a vital role in preventing the misuse of substances in horse racing and promoting the health of both the animals and the integrity of the sport.
In summary, the Racing Medication And Testing Consortium's impact is significant in upholding the standards of safety, fairness, and integrity within the horse racing community through its comprehensive approach to research, education, and advocacy efforts.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Organization Details
Founding Year
2003
Phone
(859) 224-2844
Principal Officer
Alex Waldrop
Main Address
401 WEST MAIN STREET SUITE 222, LEXINGTON, KY, 40507
Website
www.rmtcnet.com
NTEE Category
Code: D12 - Animals
If you are a representative of Racing Medication And Testing Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.